Chaim Hurvitz Nrx Pharmaceuticals, Inc. (NRXP) insider trading activity

NRXP Quotes by TradingView

Chaim Hurvitz is of NRX Pharmaceuticals, Inc.. Currently has a direct ownership of 570,000 shares of NRXP, which is worth approximately $940,500. The most recent transaction as insider was on Aug 30, 2023, when has been sold 70,000 shares (Common Stock, par value $0.001 per share) at a price of $0.29 per share, resulting in proceeds of $20,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 570K
0% 3M change
0% 12M change
Total Value Held $940,500

Chaim Hurvitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 30 2023
BUY
Open market or private purchase
$20,300 $0.29 p/Share
70,000 Added 10.94%
570,000 Common Stock, par valu...
Nov 18 2022
BUY
Open market or private purchase
$44,448 $1.1 p/Share
40,408 Added 7.48%
500,000 Common Stock
Nov 17 2022
BUY
Open market or private purchase
$185,522 $1.08 p/Share
171,780 Added 27.21%
459,592 Common Stock
Nov 16 2022
BUY
Open market or private purchase
$284,933 $0.99 p/Share
287,812 Added 50.0%
287,812 Common Stock

Also insider at

NVNT
NOVINT TECHNOLOGIES INC Communication Services
Director
CH

Chaim Hurvitz

Wilmington, DE

Track Institutional and Insider Activities on NRXP

Follow NRX Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRXP shares.

Notify only if

Insider Trading

Get notified when an Nrx Pharmaceuticals, Inc. insider buys or sells NRXP shares.

Notify only if

News

Receive news related to NRX Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRXP